| Serial Number | 87305763 |
| Word Mark | TOWA PHARMACEUTICAL |
| Filing Date | Wednesday, January 18, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 25, 2020 |
| Registration Number | 6136578 |
| Registration Date | Tuesday, August 25, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 28, 2017 |
| Goods and Services | Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals(Based on 44(e)) Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals |
| Translation of Words in Mark | The English translation of "TOWA" in the mark is "FOREVER". |
| NOT AVAILABLE | "PHARMACEUTICAL" |
| Goods and Services | Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 25, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Sunday, January 1, 2017 |
| First Use In Commerce Date | Tuesday, January 1, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 25, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, January 1, 2017 |
| First Use In Commerce Date | Tuesday, January 1, 2019 |
| Party Name | Towa Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 571-8580 JP |
| Party Name | Towa Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 571-8580 JP |
| Party Name | Towa Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 571-8580 JP |
| Event Date | Event Description |
| Thursday, April 13, 2017 | ASSIGNED TO EXAMINER |
| Saturday, January 21, 2017 | NEW APPLICATION ENTERED |
| Wednesday, January 25, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 18, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 18, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 18, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 17, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 17, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 17, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 19, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 8, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 28, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 28, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 23, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, July 22, 2018 | SOU TEAS EXTENSION RECEIVED |
| Sunday, July 22, 2018 | SOU EXTENSION 1 FILED |
| Sunday, July 22, 2018 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 24, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 23, 2019 | SOU EXTENSION 2 FILED |
| Monday, February 25, 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, February 25, 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, April 23, 2019 | TEAS PETITION TO REVIVE RECEIVED |
| Tuesday, April 23, 2019 | PETITION TO REVIVE-GRANTED |
| Tuesday, April 23, 2019 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Tuesday, April 23, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 23, 2019 | USE AMENDMENT FILED |
| Wednesday, April 24, 2019 | NOTICE OF REVIVAL - E-MAILED |
| Sunday, May 5, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sunday, May 5, 2019 | SOU EXTENSION 2 GRANTED |
| Sunday, May 5, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, May 6, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, May 7, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, May 7, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 10, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, May 15, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| Thursday, May 16, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, May 17, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Friday, May 24, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, May 24, 2019 | SU - NON-FINAL ACTION - WRITTEN |
| Friday, May 24, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, May 24, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 23, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 29, 2019 | ASSIGNED TO LIE |
| Tuesday, September 3, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 17, 2019 | FINAL REFUSAL E-MAILED |
| Tuesday, September 17, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, May 4, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, May 4, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, May 4, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 17, 2019 | SU - FINAL REFUSAL - WRITTEN |
| Wednesday, April 1, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, April 1, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, May 4, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, May 11, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 8, 2020 | ASSIGNED TO PETITION STAFF |
| Thursday, July 16, 2020 | PETITION GRANTED - RESPONSE RECEIVED |
| Thursday, July 16, 2020 | NOTICE OF REVIVAL - E-MAILED |
| Friday, July 17, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, July 18, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, July 20, 2020 | AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED |
| Tuesday, August 25, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 11, 2020 | TEAS PETITION TO REVIVE RECEIVED |
| Wednesday, April 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, April 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, April 20, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, April 20, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, April 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 20, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, April 20, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 25, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |